Search form

Industry Symposium III: Pain Management and Increasing Functional Ability for Patients with Hemophilia with Inhibitors

PrintFriendly

Printer Friendly and PDF

Industry Symposium III: Pain Management and Increasing Functional Ability for Patients with Hemophilia with Inhibitors

September 19, 2014
7:00 AM to 8:45 AM
Audience: 
Nurses

Hemophilia necessitates ongoing medical care, and this fact is magnified in patients who have developed inhibitors. Because bypassing agents, which are used when patients have inhibitors, are generally less effective than standard factor concentrates, these patients have an increased risk of uncontrolled bleeding and of progressive joint disease. Moreover, this population of patients has a need for early intervention during a bleeding event to improve the odds of bleeding control. Not surprisingly, patients with hemophilia with inhibitors struggle with pain management. Thus, patients with hemophilia with inhibitors have an extra layer of complexity added to the management of their condition, requiring special attention from nurses and the rest of the team at hemophilia treatment centers (HTCs).

Speakers: 
Michelle Witkop, DNP, FNP-BC
Kim Baumann, MPT
Georgia Panopoulos, PhD
Timothy Ringgold, MT-BC
Michael Uttecht, PT
Moderators: